太平洋生物科学 PACB
$2.26 −$0.18 (-7.20%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $2.25 -0.14%
开盘$2.43
昨收$2.43
当日区间$2.24 – $2.54
成交量9.56M
市值$705.65M
市盈率（TTM）–
股息率–
PACB 相关新闻
匹配 Pacific Biosciences of California 或代码 PACB 的头条新闻，按最新排序。
- CCORF Maintains Pacific Biosciences of California(PACB.US) With Buy Rating
- Piper Sandler Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $2
- TD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3
- Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX)
- CCORF Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3
- Analysts Are Bullish on Top Healthcare Stocks: Pacific Biosciences (PACB), 20/20 Biolabs, Inc. (AIDX) 正面
- Barclays Maintains Pacific Biosciences of California(PACB.US) With Sell Rating, Cuts Target Price to $1 负面
- Barclays Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Raises Target Price to $2 正面
- Barclays Maintains Pacific Biosciences of California(PACB.US) With Sell Rating, Maintains Target Price $1.25
- Stephens Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Raises Target Price to $2.5 正面
- Bernstein Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Raises Target Price to $1.7 正面
- TR | OpenAI - 4o Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $1.5
- Morgan Stanley Initiates Pacific Biosciences of California(PACB.US) With Hold Rating, Announces Target Price $2
- Morgan Stanley Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $2
- Piper Sandler Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Cuts Target Price to $1.25 负面
暂无评论——快来第一个聊聊 PACB。
登录后参与讨论。